Since the preliminary report on the use of mepacrine in the treatment of rheumatoid arthritis (Freedman and Bach, 1952), there has been a gradual appreciation of the value of 4-amino quinolone compounds for this condition. Many papers have appeared (Forestier and Certonciny, 1954; Scherbel, Schuchter, and Harrison, 1957; Erlendsson, 1958; Fuld and Horwich, 1958) , but controlled trials have been few. The first (Freedman, 1956 ) dealt with 66 patients each observed for a period of 16 weeks. The finding that the chloroquine-treated patients did better than the controls was confirmed by trials undertaken by Rinehart, Rosenbaum, and Hopkins (1957) , Cohen and Calkins (1958), and Kuipers (1959) Cobb, Jacox, and Jessar, 1957) .
Since the preliminary report on the use of mepacrine in the treatment of rheumatoid arthritis (Freedman and Bach, 1952) , there has been a gradual appreciation of the value of 4-amino quinolone compounds for this condition. Many papers have appeared (Forestier and Certonciny, 1954; Scherbel, Schuchter, and Harrison, 1957; Erlendsson, 1958;  Fuld and Horwich, 1958) , but controlled trials have been few. The first (Freedman, 1956 ) dealt with 66 patients each observed for a period of 16 weeks. The finding that the chloroquine-treated patients did better than the controls was confirmed by trials undertaken by Rinehart, Rosenbaum, and Hopkins (1957) , Cohen and Calkins (1958) , and Kuipers (1959) , in none of which was the period of comparison longer than 26 weeks. Bagnall (1957) , convinced of the value of these drugs, abandoned his intention to conduct a controlled trial and published his findings of 4 years' treatment of patients, the longest series yet reported. With one equivocal exception (La Tona and Norcross, 1959) , there has been widespread approbation by all authors for these compounds. The present report deals with observations in a double blindfold trial begun in 1956 in a group of patients each of whom was treated for a period of one year.
Method
Subjects.-Patients were drawn from those attending the Department of Physical Medicine at the London Hospital, those under the care of one of us at Hackney Hospital, and those from the Department of Physical Medicine at Chase Farm Hospital, Enfield.
Diagnostic Criteria.-Patients with rheumatoid type of arthritis with active inflammation of at least four joints and a raised erythrocyte sedimentation rate were admitted irrespective of the duration of the disease or the result of the sheep-cell agglutination test. These patients all satisfied the criteria as having definite rheumatoid arthritis according to the classification of the American Rheumatism Association (Ropes, Bennett, Cobb, Jacox, and Jessar, 1957) .
Patients ill enough to be admitted to hospital were not accepted into the trial, and anyone within the trial was withdrawn if the condition so deteriorated as to warrant admission to hospital.
Treatment.-During the trial period all patients received eight 5-gr. tablets of enteric-coated aspirin daily, and if they were anaemic oral iron was also prescribed. The patients also received either chloroquine or dummy tablets of identical appearance, the physician not knowing which kind the patient was having throughout the trial. These tablets were prescribed according to the serial number given to the patient as each was admitted into the trial. A list of these numbers divided randomly into two groups, P and Q, was held by the pharmacist, who dispensed either P or Q tablets according to the serial number. The dispenser did not know which was the active preparation. Those patients who were receiving the active preparation were in fact taking chloroquine sulphate 200 mg. twice daily. In a few cases in both groups side-effects occurred; these were considered to be toxic effects and a reduction of dosage to one and a half tablets daily was made. Appropriate splinting and physiotherapy were also prescribed.
Assessment.-The patients were examined by one of us at a special clinic held for this purpose on a separate afternoon. At each visit they were asked specific questions concerning their symptoms and their need for analgesics other than those routinely prescribed, and about any change in their self-care and ability to work.
Special note was made of their colour, and the pre-part The time taken to walk 25 yards was recorded as the walking-time.
The dexterity of the hands was measured by recording the time taken to insert a lace in and out of the holes on one side of a boot.
The patients were assessed at intervals of 2 to 6 weeks. At each visit they were weighed and blood was taken for haemoglobin and erythrocyte sedimentation rate tests.
Blood for sheep-cell agglutination tests was taken at the beginning and the end of the year, as were x-rays of the hands and feet.
At the end of the trial these records provided figures expressing the degree of joint inflammation and joint function, and data from which subjective and objective clinical assessments could be made.
Material
There were 53 patients in the chloroquine group Strength of Grip (Table V) .-The mean strength 220 of grip of the forty controls at the start of treatment making a possible total of 100. (Table VI) .-There was no significant change in either group.
Erythrocyte Sedimentation Rate (Table VI) .-Only the chloroquine group showed a significant improvement during the year, an average fall of 10 1 mm./hr (Westergren) (t = 3-771; p <0-001).
Radiological Changes (Table VII) (Table III) . The tests used to demonstrate this did, it must be admitted, depend on the examiner's assessment and the co-operation of the patient. However, the erythrocyte sedimentation rate was an entirely objective estimation and this too showed a significant improvement in the chloroquine group. The changes in technique in the haemagglutination tests were unfortunate, but we feel that the results should not be dismissed, first because these changes would have affected both groups equally, and secondly because the changes of method made the tests more sensitive, so that more positive results would be detected at the final examination. Confirmation of this very favourable response to chloroquine is of some importance, since it contrasts with the increase in haemagglutination titres that occurred in patients receiving prednisone (Medical Research Council and Nuffield Foundation, 1959 ). The differences observed in the progression of x-ray changes in the two groups should not perhaps be used as an argument in favour of chloroquine. A longer period of observation and a more detailed assessment of individual joints should be undertaken to provide a system of scoring for use by the statistician.
Safety of Chloroquine.-Side-effects of various kinds occurred in 33 cases (62-5 per cent.), but the fact that similar symptoms also occurred in 22 (40 per cent.) of the control cases shows that it should not be assumed that the drug is alone responsible. A small reduction in dosage may enable the patient to tolerate the drug and yet have worthwhile benefit. In this investigation, with a maximum dosage of 400 mg. chloroquine sulphate daily for one year, no irreversible toxic effect occurred. Experience outside this trial (Hobbs, Sorsby, and Freedman, 1959) Cloroquina en artritis reumatoide.-Ensayo a "doble disfraz" de tratamiento por un aiio SUMARIO Se describen los resultados de un ensayo a "doble disfraz" (double blind), en el que enfermos con artritis reumatoide recibieron unos cloroquina, otros pastillas inertes, apropiadamente disfrazadas. Entre los tres centros participantes en la prueba se reunieron 107 enfermos; 53 de ellos recibieron el medicamento y los otros 54 la substancia inerte. La dosis de sulfato de cloroquina fue 400 mg. diarios. Todos los enfermos recibieron al mismo tiempo aproximadamente 2,7 g. diarios de aspirina y la adecuada fisioterapia.
Fueron retirados de la investigacion por diversas causas 25 enfermos, 14 entre el grupo de control y 11 entre 6l que tomaba cloroquina. Efectos toxicos fueron responsables de cinco casos retirados en el grupo tratado con cloroquina y de cuatro casos en el de control. Tres de los casos del grupo de control se agravaron tanto, que tuvieron que ser retirados de la investigation.
Quedaron, por tanto, 40 enfermos en el grupo de control y 42 en el grupo tratado con cloroquina, durante un ano.
Los enfermos que recibieron y toleraron la cloroquina presentaron una mejoria estadisticamente significative con respecto a los indicios de valoracion clinica y velocidad de sedimentaci6n eritrocitaria. No se aprecio cambio alguno en el termino medio de la cifra de hemoglobin.
Reacciones de hemaglutinacion se llevaron a cabo por diferentes metodos durante el periodo de investigaci6n; los cambios observados indicaron una clara mejoria en los pacientes del grupo que recibio cloroquina. Los datos radiologicos no fueron sometidos a anAisis estadistico, pero tendian a mostrar una progresi6n mAs lenta en el grupo tratado que en el grupo de control.
Mejoria general definida se present en el 30 por ciento de los 40 enfermos de control y en el 80 por ciento de los 42 que completaron un aflo de tratamiento con cloroquina. Una agravacion de la sintomatologia se observe en el 25 por ciento del grupo de control y solamente en el 5 por ciento del grupo en tratamiento.
El sulfato de cloroquina a la dosis administrada, durante un afno, demostr6 ser perfectamente seguro.
